Dyspepsia and Helicobacter pylori.
作者信息
Shah Rupal
出版信息
BMJ. 2007 Jan 6;334(7583):41-3. doi: 10.1136/bmj.39014.468900.BE.
Abstract
摘要
相似文献
1
Dyspepsia and Helicobacter pylori.
BMJ. 2007 Jan 6;334(7583):41-3. doi: 10.1136/bmj.39014.468900.BE.
2
Testing for Helicobacter pylori in primary care: trouble in store?
J Epidemiol Community Health. 1998 May;52(5):305-9. doi: 10.1136/jech.52.5.305.
3
Management of Helicobacter pylori infection. Eradication treatment should be limited to patients with proved peptic ulceration.
BMJ. 1998 Apr 18;316(7139):1244-5. doi: 10.1136/bmj.316.7139.1244b.
4
Clinical aspects of infection with Helicobacter pylori.
Commun Dis Rep CDR Rev. 1993 Mar 26;3(4):R59-62.
5
Testing for Helicobacter pylori in dyspeptic patients. Authors' suggestion muddies waters in debate.
BMJ. 2001 Nov 3;323(7320):1066-7; author reply 1067-8.
6
Economic perspectives in the management of Helicobacter pylori infections.
Curr Top Microbiol Immunol. 1999;241:237-60. doi: 10.1007/978-3-642-60013-5_12.
7
Helicobacter pylori test-and-eradication strategy.
Lancet. 2000 Nov 11;356(9242):1683-4. doi: 10.1016/s0140-6736(05)70386-x.
8
Helicobacter pylori serology in evaluation of dyspepsia.
Am Fam Physician. 1998 Feb 15;57(4):631-2.
9
Common-sense management of Helicobacter pylori-associated gastroduodenal disease. Personal views.
Gastroenterol Clin North Am. 1993 Mar;22(1):199-206.
10
Dyspepsia management in primary care in The Netherlands: to what extent is Helicobacter pylori diagnosis and treatment incorporated? Results from a survey among general practitioners in The Netherlands.
Digestion. 2001;64(1):40-5. doi: 10.1159/000048837.
引用本文的文献
1
Peptic ulcer and childhood adversities experienced by working-aged people.
World J Gastroenterol. 2009 Jul 21;15(27):3405-10. doi: 10.3748/wjg.15.3405.
本文引用的文献
1
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
BMJ. 2006 Jan 28;332(7535):199-204. doi: 10.1136/bmj.38702.662546.55. Epub 2006 Jan 20.
2
Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
BMJ. 2005 Dec 3;331(7528):1310-6. doi: 10.1136/bmj.331.7528.1310.
3
Initial management strategies for dyspepsia.
Cochrane Database Syst Rev. 2005 Oct 19(4):CD001961. doi: 10.1002/14651858.CD001961.pub2.
4
H. pylori eradication in NSAID-associated ulcers.
Drug Ther Bull. 2005 May;43(5):37-40. doi: 10.1136/dtb.2005.43537.
5
The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.
BMJ. 2004 Oct 23;329(7472):948. doi: 10.1136/bmj.38232.680567.EB. Epub 2004 Oct 8.
6
Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project.
BMJ. 2004 Jun 12;328(7453):1417. doi: 10.1136/bmj.38082.626725.EE. Epub 2004 May 4.
7
Guidelines for the management of oesophageal and gastric cancer.
Gut. 2002 Jun;50 Suppl 5(Suppl 5):v1-23. doi: 10.1136/gut.50.90005.v1.
8
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.
BMJ. 2002 Apr 27;324(7344):1012-6. doi: 10.1136/bmj.324.7344.1012.
9
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.
Gastroenterology. 1997 May;112(5):1442-7. doi: 10.1016/s0016-5085(97)70024-6.
Zotero 插件